Parallax Volatility Advisers’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,500
Closed -$410K 1574
2025
Q1
$410K Sell
4,500
-53,400
-92% -$5.98M ﹤0.01% 1223
2024
Q4
$6.6M Buy
57,900
+28,600
+98% +$3.26M 0.01% 721
2024
Q3
$3.48M Sell
29,300
-25,300
-46% -$2.33M 0.01% 941
2024
Q2
$4.39M Buy
54,600
+32,000
+142% +$2.93M 0.01% 763
2024
Q1
$2.08M Hold
22,600
﹤0.01% 1013
2023
Q4
$2.39M Buy
22,600
+7,000
+45% +$705K ﹤0.01% 1107
2023
Q3
$1.69M Sell
15,600
-56,400
-78% -$6.24M ﹤0.01% 1156
2023
Q2
$7.77M Buy
+72,000
New +$8.1M 0.02% 613
2023
Q1
Sell
-38,000
Closed -$5.71M 2743
2022
Q4
$5.71M Buy
38,000
+7,800
+26% +$1.2M 0.01% 974
2022
Q3
$4.07M Sell
30,200
-22,400
-43% -$3.42M 0.01% 1111
2022
Q2
$7.84M Buy
52,600
+30,900
+142% +$4.72M 0.01% 821
2022
Q1
$3.7M Buy
+21,700
New +$3.65M ﹤0.01% 1105

Other funds holding BNTX

Parallax Volatility Advisers's BNTX Position: Q3 2025 in Review

Parallax Volatility Advisers sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 2,447 shares — an estimated $261K sold.

Parallax Volatility Advisers first reported a position in BNTX in Q1 2022 and held it in 14 quarters. The position peaked at $11.9M in Q1 2022. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Parallax Volatility Advisers reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,447 BioNTech shares in Q3 2025, an estimated $261K.
  • Parallax Volatility Advisers first reported a position in BioNTech in Q1 2022 and held it in 14 quarters.
  • Parallax Volatility Advisers's BioNTech position peaked at $11.9M in Q1 2022.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.